2018
DOI: 10.1016/j.antiviral.2018.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Host-based processes as therapeutic targets for Rift Valley fever virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 153 publications
0
4
0
Order By: Relevance
“…In the context of RVF-induced developmental anomalies, a recent publication, which presented transcriptomic data of the human host response following RVFV infection, demonstrated downregulation of the host gene for miR-17-92 [ 26 ]. The miR-17–92 family collectively encodes a total of 15 miRNAs that are essential for the development of vertebrates, and deregulation is involved in the pathogenesis of a variety of human diseases, especially congenital developmental disorders [ 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the context of RVF-induced developmental anomalies, a recent publication, which presented transcriptomic data of the human host response following RVFV infection, demonstrated downregulation of the host gene for miR-17-92 [ 26 ]. The miR-17–92 family collectively encodes a total of 15 miRNAs that are essential for the development of vertebrates, and deregulation is involved in the pathogenesis of a variety of human diseases, especially congenital developmental disorders [ 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…Rift Valley Fever virus (RVFV) is an enveloped, segmented, negative-sense RNA virus that replicates in the cytoplasm of host cells [ 79 ]. Its genome consists of L, M, and S segments, and it is primarily transmitted by mosquitoes.…”
Section: Role Of Exosomes and Autophagy Crosstalk In Enveloped Virus ...mentioning
confidence: 99%
“…Particularly, host-cell related pathways (e.g. transcriptional and mitochondrial processes) utilised by RVFV for its replication, are promising therapeutic targets for anti-RVFV drug development [116].…”
Section: Chalcone Derivatives Tested On Rift Valley Fevermentioning
confidence: 99%